Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Coleen Cunningham, MD
University of California, Irvine
Study Chair - Ruth Karron, MD
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health (JHSPH)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- David Geffen School of Medicine at Ucla Nichd Crs
Los Angeles, California, United States
- University of California, Uc San Diego Crs- Mother-Child-Adolescent Hiv Program
San Diego, California, United States
- Univ. of Colorado Denver Nichd Crs
Aurora, Colorado, United States
- Emory University School of Medicine Nichd Crs
Atlanta, Georgia, United States
- Lurie Children'S Hospital of Chicago (lch) Crs
Chicago, Illinois, United States
- Rush Univ. Cook County Hosp. Chicago Nichd Crs
Chicago, Illinois, United States
- University of Maryland School of Medicine Center for Vaccine Development Crs
Baltimore, Maryland, United States
- the Children'S Mercy Hospital Crs
Kansas City, Missouri, United States
- Center for Vaccine Development Crs
St Louis, Missouri, United States
- Suny Stony Brook Nichd Crs
Stony Brook, New York, United States
- Jacobi Med. Ctr. Bronx Nichd Crs
The Bronx, New York, United States
- Duke Vaccine and Trials Unit Crs
Durham, North Carolina, United States
- Gamble Center for Clinical Studies Crs
Cincinnati, Ohio, United States
- Baylor College of Medicine/ Texas Children'S Hospital Nichd Crs
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jun 2019
- Primary completion
- 22 Jan 2024
- Completion
- 25 Apr 2024
- Last update posted
- 21 Feb 2025
- Registered enrollment
- 67
- Registry id
- NCT03916185
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.